JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110594200 on December 20, 2001

J. Biol. Chem., Vol. 277, Issue 10, 8724-8729, March 8, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/10/8724    most recent
M110594200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, R.
Right arrow Articles by Ferrara, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, R.
Right arrow Articles by Ferrara, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of Endocrine Gland-derived Vascular Endothelial Growth Factor Signaling in Adrenal Cortex Capillary Endothelial Cells*

Rui Lin, Jennifer LeCouter, Joe Kowalski, and Napoleone FerraraDagger

From the Department of Molecular Oncology, Genentech Inc., South San Francisco, California 94080

Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) has been recently identified as a mitogen specific for the endothelium of steroidogenic glands. Here we report a characterization of the signal transduction of EG-VEGF in a responsive cell type, bovine adrenal cortex-derived endothelial (ACE) cells. EG-VEGF led to a time- and dose-dependent phosphorylation of p44/42 MAPK. This effect was blocked by pretreatment with pertussis toxin, suggesting that Galpha i plays an important role in mediating EG-VEGF-induced activation of MAPK signaling. The inhibitor of p44/42 MAPK phosphorylation PD 98059 resulted in suppression of both proliferation and migration in response to EG-VEGF. EG-VEGF also increased the phosphorylation of Akt in a phosphatidylinositol 3-kinase-dependent manner. Consistent with such an effect, EG-VEGF was a potent survival factor for ACE cells. We also identified endothelial nitric-oxide synthase as one of the downstream targets of Akt activation. Phosphorylation of endothelial nitric-oxide synthase in ACE cells was stimulated by EG-VEGF with a time course correlated to the Akt phosphorylation. Our data demonstrate that EG-VEGF, possibly through binding to a G-protein coupled receptor, results in the activation of MAPK p44/42 and phosphatidylinositol 3-kinase signaling pathways, leading to proliferation, migration, and survival of responsive endothelial cells.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Molecular Oncology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080. Tel.: 650-225-2968; Fax: 650-225-6327; E-mail: nf@gene.com.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
F. C. Denison, S. Battersby, A. E. King, M. Szuber, and H. N. Jabbour
Prokineticin-1: A Novel Mediator of the Inflammatory Response in Third-Trimester Human Placenta
Endocrinology, July 1, 2008; 149(7): 3470 - 3477.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Evans, R. D. Catalano, K. Morgan, H. O. D. Critchley, R. P. Millar, and H. N. Jabbour
Prokineticin 1 Signaling and Gene Regulation in Early Human Pregnancy
Endocrinology, June 1, 2008; 149(6): 2877 - 2887.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Keramidas, C. Faudot, A. Cibiel, J.-J. Feige, and M. Thomas
Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells
J. Endocrinol., March 1, 2008; 196(3): 473 - 482.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Shojaei, M. Singh, J. D. Thompson, and N. Ferrara
Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
PNAS, February 19, 2008; 105(7): 2640 - 2645.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. S.W. Ngan, F. Y.L. Sit, K. L. Lee, X. Miao, Z. Yuan, W. Wang, J. M. Nicholls, K. K.Y. Wong, M. Garcia-Barcelo, V. C.H. Lui, et al.
Implications of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 Signaling in Human Neuroblastoma Progression
Clin. Cancer Res., February 1, 2007; 13(3): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
Q.-Y. Zhou
The Prokineticins: A NOVEL PAIR OF REGULATORY PEPTIDES
Mol. Interv., December 1, 2006; 6(6): 330 - 338.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Hoffmann, J.-J. Feige, and N. Alfaidy
Expression and Oxygen Regulation of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 and Its Receptors in Human Placenta during Early Pregnancy
Endocrinology, April 1, 2006; 147(4): 1675 - 1684.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-i. Matsumoto, C. Yamazaki, K.-h. Masumoto, M. Nagano, M. Naito, T. Soga, H. Hiyama, M. Matsumoto, J. Takasaki, M. Kamohara, et al.
Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2.
PNAS, March 14, 2006; 103(11): 4140 - 4145.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. S. W. Ngan, K. Y. Lee, W. S. B. Yeung, H. Y. S. Ngan, E. H. Y. Ng, and P. C. Ho
Endocrine Gland-Derived Vascular Endothelial Growth Factor Is Expressed in Human Peri-implantation Endometrium, But Not in Endometrial Carcinoma
Endocrinology, January 1, 2006; 147(1): 88 - 95.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Kisliouk, H. Podlovni, K. Spanel-Borowski, O. Ovadia, Q.-Y. Zhou, and R. Meidan
Prokineticins (Endocrine Gland-Derived Vascular Endothelial Growth Factor and BV8) in the Bovine Ovary: Expression and Role as Mitogens and Survival Factors for Corpus Luteum-Derived Endothelial Cells
Endocrinology, September 1, 2005; 146(9): 3950 - 3958.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Dorsch, Y. Qiu, D. Soler, N. Frank, T. Duong, A. Goodearl, S. O'Neil, J. Lora, and C. C. Fraser
PK1/EG-VEGF induces monocyte differentiation and activation
J. Leukoc. Biol., August 1, 2005; 78(2): 426 - 434.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Chen, C. Kuei, S. Sutton, S. Wilson, J. Yu, F. Kamme, C. Mazur, T. Lovenberg, and C. Liu
Identification and Pharmacological Characterization of Prokineticin 2{beta} as a Selective Ligand for Prokineticin Receptor 1
Mol. Pharmacol., June 1, 2005; 67(6): 2070 - 2076.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. LeCouter, C. Zlot, M. Tejada, F. Peale, and N. Ferrara
Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization
PNAS, November 30, 2004; 101(48): 16813 - 16818.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. M. Bullock, J.-D. Li, and Q.-Y. Zhou
Structural Determinants Required for the Bioactivities of Prokineticins and Identification of Prokineticin Receptor Antagonists
Mol. Pharmacol., March 1, 2004; 65(3): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kisliouk, N. Levy, A. Hurwitz, and R. Meidan
Presence and Regulation of Endocrine Gland Vascular Endothelial Growth Factor/Prokineticin-1 and Its Receptors in Ovarian Cells
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3700 - 3707.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. LeCouter, R. Lin, G. Frantz, Z. Zhang, K. Hillan, and N. Ferrara
Mouse Endocrine Gland-Derived Vascular Endothelial Growth Factor: A Distinct Expression Pattern from Its Human Ortholog Suggests Different Roles as a Regulator of Organ-Specific Angiogenesis
Endocrinology, June 1, 2003; 144(6): 2606 - 2616.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. LeCouter, R. Lin, M. Tejada, G. Frantz, F. Peale, K. J. Hillan, and N. Ferrara
The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells
PNAS, March 4, 2003; 100(5): 2685 - 2690.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Zhang, N. Yang, J.-R. Conejo-Garcia, D. Katsaros, A. Mohamed-Hadley, S. Fracchioli, K. Schlienger, A. Toll, B. Levine, S. C. Rubin, et al.
Expression of Endocrine Gland-derived Vascular Endothelial Growth Factor in Ovarian Carcinoma
Clin. Cancer Res., January 1, 2003; 9(1): 264 - 272.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. F. Dvorak
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
J. Clin. Oncol., November 1, 2002; 20(21): 4368 - 4380.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.